The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 748K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

19 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Design, Synthesis, and Biological Characterization of Inhaled p38α/β MAPK Inhibitors for the Treatment of Lung Inflammatory Diseases.EBI
Chiesi Farmaceutici
Synthesis and biological activity of flurbiprofen analogues as selective inhibitors of beta-amyloid(1)(-)(42) secretion.EBI
Chiesi Farmaceutici
Discovery of Clinical Candidate CHF-6366: A Novel Super-soft Dual Pharmacology Muscarinic Antagonist and βEBI
Chiesi Farmaceutici
Discovery of MEBI
Chiesi Farmaceutici
Discovery of a novel class of inhaled dual pharmacology muscarinic antagonist and βEBI
Chiesi Farmaceutici
Novel class of benzoic acid ester derivatives as potent PDE4 inhibitors for inhaled administration in the treatment of respiratory diseases.EBI
Chiesi Farmaceutici
Discovery and Optimization of Thiazolidinyl and Pyrrolidinyl Derivatives as Inhaled PDE4 Inhibitors for Respiratory Diseases.EBI
Chiesi Farmaceutici
PDE4B INHIBITOR AND USE THEREOFBDB
Xizang Haisco Pharmaceutical Co.
METHIONINE ADENOSYLTRANSERASE 2A INHIBITORSBDB
Ideaya Biosciences
DUAL ANTAGONIST AND USE THEREOFBDB
Nicoya Therapeutics (Shanghai) Co.
Tricyclic Compounds and their UsesBDB
Novartis
INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE, COMPOSITIONS, AND METHODS OF USEBDB
Bristol-Myers Squibb
MACROCYCLES AND THEIR USEBDB
Blossomhill Therapeutics
NEK7 INHIBITORSBDB
Halia Therapeutics
TRK inhibitors useful as anticancer drugsBDB
TYLIGAND BIOSCIENCE (SHANGHAI) LIMITED
TRIAZOLYL-METHYL SUBSTITUTED ALPHA-D-GALACTOPYRANOSIDE DERIVATIVESBDB
Idorsia Pharmaceuticals
Substituted indazoles as IRAK4 inhibitorsBDB
Astrazeneca
Bis-amido pyridinesBDB
Boehringer Ingelheim International